{"DataElement":{"publicId":"7639797","version":"1","preferredName":"Local Induration/Swelling Injectable Product-Related Reaction Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of local induration/swelling associated to the reaction to the injectable product.","longName":"LC_SW_INJ_RCT_OC_GRD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7639755","version":"1","preferredName":"Local Induration/Swelling Injectable Product-Related Reaction Occurrence","preferredDefinition":"Of or belonging to a restricted area or locality._The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin._Used to indicate that either or both of two items or options may be valid._Enlargement; expansion in size; sign of inflammation._A reaction to the injection of a pharmacological or biological substance._An instance of something happening, such as an event or incident.","longName":"7639764v1.0:7639753v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"7639764","version":"1","preferredName":"Local Induration And/Or Swelling Injectable Product-Related Reaction","preferredDefinition":"Of or belonging to a restricted area or locality.:The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.:Used to indicate that either or both of two items or options may be valid.:Enlargement; expansion in size; sign of inflammation:A reaction to the injection of a pharmacological or biological substance.","longName":"7639764v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local","conceptCode":"C67263","definition":"Of or belonging to a restricted area or locality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Induration","conceptCode":"C25534","definition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Swelling","conceptCode":"C3399","definition":"Enlargement; expansion in size; sign of inflammation","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Injectable Product-Related Reaction","conceptCode":"C179192","definition":"A reaction to the injection of a pharmacological or biological substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091C796-C333-4735-E053-4EBD850A30B6","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"ONEDATA","dateModified":"2021-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7639753","version":"1","preferredName":"Local Induration And/Or Swelling Occurrence","preferredDefinition":"Of or belonging to a restricted area or locality.:The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.:Used to indicate that either or both of two items or options may be valid.:Enlargement; expansion in size; sign of inflammation:An instance of something happening, such as an event or incident.","longName":"7639753v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local","conceptCode":"C67263","definition":"Of or belonging to a restricted area or locality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Induration","conceptCode":"C25534","definition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Swelling","conceptCode":"C3399","definition":"Enlargement; expansion in size; sign of inflammation","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C09186A2-E2CB-598D-E053-4EBD850A98E1","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"ONEDATA","dateModified":"2021-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008575","version":"1","preferredName":"Symptoms","preferredDefinition":"signs that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain(NCI). ","longName":"SM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB883C03-CF97-2540-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"MSUPLEY","dateModified":"2004-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C09186A2-E2DC-598D-E053-4EBD850A98E1","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeDescription":"Approved and released. 2021-4-23 ak; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7639776","version":"1","preferredName":"Reactogenicity Grade","preferredDefinition":"An expected set of reactions that may occur soon after injection of a vaccine. These expected adverse reactions are a physical manifestation of the inflammatory response to the vaccine._A position on a scale of intensity or amount or quality.","longName":"REACTOGEN_GRD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Potentially Life Threatening (Grade 4)","valueDescription":"Potentially Life Threatening","ValueMeaning":{"publicId":"7639777","version":"1","preferredName":"Potentially Life Threatening","longName":"7639777","preferredDefinition":"Potentially Life Threatening","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-67E9-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C091ABA9-6802-1D5C-E053-4EBD850ABD42","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"ONEDATA","dateModified":"2021-04-22","deletedIndicator":"No"},{"value":"Severe (Grade 3)","valueDescription":"Severe","ValueMeaning":{"publicId":"7639778","version":"1","preferredName":"Severe","longName":"7639778","preferredDefinition":"Severe","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-680C-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C091ABA9-6825-1D5C-E053-4EBD850ABD42","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"ONEDATA","dateModified":"2021-04-22","deletedIndicator":"No"},{"value":"Moderate (Grade 2)","valueDescription":"Moderate","ValueMeaning":{"publicId":"7639779","version":"1","preferredName":"Moderate","longName":"7639779","preferredDefinition":"Moderate","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-682F-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C091ABA9-6848-1D5C-E053-4EBD850ABD42","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"ONEDATA","dateModified":"2021-04-22","deletedIndicator":"No"},{"value":"Mild (Grade 1)","valueDescription":"Mild","ValueMeaning":{"publicId":"7639780","version":"1","preferredName":"Mild","longName":"7639780","preferredDefinition":"Mild","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-6852-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C091ABA9-686B-1D5C-E053-4EBD850ABD42","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"ONEDATA","dateModified":"2021-04-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7639775","version":"1","preferredName":"Reactogenicity Grade","preferredDefinition":"An expected set of reactions that may occur soon after injection of a vaccine. These expected adverse reactions are a physical manifestation of the inflammatory response to the vaccine.:A position on a scale of intensity or amount or quality.","longName":"C179193:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reactogenicity","conceptCode":"C179193","definition":"An expected set of reactions that may occur soon after injection of a vaccine. These expected adverse reactions are a physical manifestation of the inflammatory response to the vaccine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-67C1-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"ONEDATA","dateModified":"2021-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-67D2-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-24","changeDescription":"Approved and released. 2021-4-23 ak Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Local Induration/Swelling Rea","type":"Preferred Question Text","description":"Local Induration/Swelling Reaction to Injectable Product Grade","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0932074-0A45-277E-E053-4EBD850A0E31","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeDescription":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}